The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter.
The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible.
Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change.
All content for Strategy& Insider is the property of Thomas Solbach, Ghioia Irritier, Jan-Philipp Loch and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter.
The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible.
Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change.
Strategy& Insider Episode 31 - Advancing breakthroughs in rare disease research
Strategy& Insider
43 minutes
8 months ago
Strategy& Insider Episode 31 - Advancing breakthroughs in rare disease research
In this episode, we explore the forefront of rare disease research with Professor Matthew Wood, the Director and Chief Scientific Officer at the Oxford-Harrington Rare Disease Centre (OHC). Professor Wood shares his inspiring journey from his early studies in Cape Town to his impactful career at Oxford University. Learn about the innovative initiatives at OHC and their ambitious plan to bring 40 drugs into clinical trials within the next decade. This episode provides valuable insights into the challenges and opportunities in rare disease treatment, presenting a hopeful vision for rapid diagnosis and effective therapies.
Strategy& Insider
The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter.
The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible.
Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change.
